Other
Deferred Taxes
Bristol-Myers Squibb Deferred Taxes decreased by 5.0% to $211.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.6%, from $276.00M to $211.00M. Over 5 years (FY 2020 to FY 2025), Deferred Taxes shows a downward trend with a -47.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
Detailed definition
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Peer comparison
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
Metric ID:
other_deferred_income_tax_liabilities_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.93B | $4.96B | $4.50B | $3.81B | $3.03B | $2.88B | $2.17B | $1.57B | $751.00M | $399.00M | $338.00M | $442.00M | $461.00M | $430.00M | $369.00M | $276.00M | $247.00M | $225.00M | $222.00M | $211.00M |
| QoQ Change | — | +0.5% | -9.2% | -15.4% | -20.3% | -5.0% | -24.8% | -27.6% | -52.1% | -46.9% | -15.3% | +30.8% | +4.3% | -6.7% | -14.2% | -25.2% | -10.5% | -8.9% | -1.3% | -5.0% |
| YoY Change | — | — | — | — | -38.5% | -41.9% | -51.9% | -58.8% | -75.2% | -86.2% | -84.4% | -71.8% | -38.6% | +7.8% | +9.2% | -37.6% | -46.4% | -47.7% | -39.8% | -23.6% |
Range$211.00M – $4.96B
CAGR-48.5%
Avg YoY Growth-45.3%
Median YoY Growth-44.1%
Current Streak7 quarters decline
Deferred Taxes at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's deferred taxes?
- Bristol-Myers Squibb (BMY) reported deferred taxes of $211.00M in Q1 2026.
- How has Bristol-Myers Squibb's deferred taxes changed year-over-year?
- Bristol-Myers Squibb's deferred taxes decreased by 23.6% year-over-year, from $276.00M to $211.00M.
- What is the long-term trend for Bristol-Myers Squibb's deferred taxes?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's deferred taxes has grown at a -47.2% compound annual growth rate (CAGR), from $5.41B to $222.00M.
- What does deferred taxes mean?
- Future tax payments the company expects to make due to timing differences in accounting.